http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2009011421-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-502
filingDate 2008-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a38114230ebb34b3f44f08b22f02deda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93d529f5cb823fc834dc8c69406716a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_351c86f1c8797314515827262f9f69f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83eabb4e7d5cddf17369db434e8b15c8
publicationDate 2009-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2009011421-A
titleOfInvention DERIVATIVES OF FTALAZINE AND ISOQUINOLINE WITH MODULATING ACTIVITIES OF THE S1P RECEIVER.
abstract The invention relates to novel heterocyclic compounds of the formula (I) in which all the variables are as defined in the specification, in free form or in salt form, as well as with their preparation, with their use as medicaments and with the medications that contain them.
priorityDate 2007-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410792880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456414897

Total number of triples: 35.